Vascular Closure Devices Market Size, Share, Growth Forecast Through 2034

According to Fortune Business Insights, the global vascular closure devices market was valued at USD 2.11 billion in 2025 and is projected to grow from USD 2.28 billion in 2026 to USD 4.92 billion by 2034, exhibiting a CAGR of 10.10% during the forecast period.

The global vascular closure devices market is witnessing strong growth, driven by the increasing number of cardiovascular procedures and the rising adoption of minimally invasive technologies. The vascular closure devices (VCDs) are essential medical tools used to achieve hemostasis after catheter-based procedures, helping reduce bleeding complications and recovery time.

Vascular closure devices are widely used following procedures such as angiography, angioplasty, and other interventional cardiology treatments. These devices offer advantages over traditional manual compression, including faster patient recovery, reduced hospital stay, and improved patient comfort.

This robust growth is primarily attributed to the rising prevalence of cardiovascular diseases, increasing geriatric population, and growing demand for minimally invasive procedures. The rapid expansion of healthcare infrastructure, particularly in emerging economies, is further supporting market development.

Information Source: https://www.fortunebusinessinsights.com/vascular-closure-devices-market-109964 

Key Market Drivers

One of the major factors fueling market growth is the increasing incidence of cardiovascular disorders worldwide. As conditions such as coronary artery disease and peripheral artery disease become more common, the number of catheter-based diagnostic and therapeutic procedures is rising significantly.

Another important driver is the shift toward minimally invasive surgeries. These procedures require efficient and reliable closure of vascular access points, making VCDs indispensable. Additionally, technological advancements, including bioabsorbable materials and improved device designs, are enhancing safety and efficiency.

The demand for rapid hemostasis solutions is also contributing to market expansion. Hospitals and healthcare providers prefer devices that minimize complications and enable faster patient mobilization and discharge.

Market Segmentation Insights

The vascular closure devices market is segmented based on product type, access site, procedure, and end user.

By product type, plug-based devices are expected to dominate the market due to their ability to provide quick hemostasis and reduced complication rates.

Based on access type, the market is divided into femoral and radial access devices, with femoral access currently holding a significant share due to its widespread use in interventional procedures.

In terms of application, interventional cardiology accounts for the largest share, driven by the high volume of cardiac catheterization procedures globally.

Hospitals remain the leading end users, followed by ambulatory surgical centers, as they perform a large number of vascular procedures requiring closure devices.

Regional Analysis

North America dominates the global vascular closure devices market, accounting for 43.30% of the market share in 2025.This dominance is attributed to advanced healthcare infrastructure, high healthcare spending, and the growing number of interventional cardiology procedures.

Europe holds the second-largest share, supported by well-established healthcare systems and increasing adoption of advanced medical technologies.

The Asia Pacific region is expected to witness the fastest growth during the forecast period. Factors such as improving healthcare infrastructure, rising awareness, and increasing patient population are driving demand in countries like China and India.

Competitive Landscape and Key Players

The vascular closure devices market is highly competitive, with several global and regional players focusing on innovation and strategic collaborations to strengthen their market position. Key players include:

• Abbott Laboratories

• Medtronic plc

• Becton, Dickinson and Company

• Cardinal Health Inc.

• Teleflex Incorporated

• Haemonetics Corporation

• Cordis Corporation

• Terumo Corporation

These companies are investing heavily in research and development to introduce innovative products with enhanced safety and efficiency.

Market Challenges

Despite strong growth prospects, the market faces certain challenges. The high cost of vascular closure devices compared to traditional manual compression methods can limit adoption, particularly in cost-sensitive regions. Additionally, stringent regulatory requirements may delay product approvals and market entry.

Another concern is the need for skilled professionals to operate these devices effectively, which can act as a barrier in developing regions.

Conclusion

The vascular closure devices market is poised for significant growth, driven by the increasing burden of cardiovascular diseases and the rising demand for minimally invasive procedures. Technological advancements and expanding healthcare infrastructure are further accelerating adoption.